Your browser doesn't support javascript.
loading
Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models.
Keklikoglou, Ioanna; Cianciaruso, Chiara; Güç, Esra; Squadrito, Mario Leonardo; Spring, Laura M; Tazzyman, Simon; Lambein, Lore; Poissonnier, Amanda; Ferraro, Gino B; Baer, Caroline; Cassará, Antonino; Guichard, Alan; Iruela-Arispe, M Luisa; Lewis, Claire E; Coussens, Lisa M; Bardia, Aditya; Jain, Rakesh K; Pollard, Jeffrey W; De Palma, Michele.
Afiliación
  • Keklikoglou I; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. ioanna.keklikoglou@epfl.ch.
  • Cianciaruso C; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
  • Güç E; MRC Centre for Reproductive Health, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK.
  • Squadrito ML; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
  • Spring LM; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Tazzyman S; Department of Oncology and Metabolism, Medical School, University of Sheffield, Sheffield, UK.
  • Lambein L; Department of Oncology and Metabolism, Medical School, University of Sheffield, Sheffield, UK.
  • Poissonnier A; Department of Cell, Developmental and Cancer Biology, Oregon Health and Sciences University, Portland, OR, USA.
  • Ferraro GB; Edwin L. Steele Laboratories, Department of Radiation Oncology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
  • Baer C; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
  • Cassará A; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
  • Guichard A; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
  • Iruela-Arispe ML; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
  • Lewis CE; Department of Molecular Cell and Developmental Biology, Molecular Biology Institute, Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA.
  • Coussens LM; Department of Oncology and Metabolism, Medical School, University of Sheffield, Sheffield, UK.
  • Bardia A; Department of Cell, Developmental and Cancer Biology, Oregon Health and Sciences University, Portland, OR, USA.
  • Jain RK; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Pollard JW; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • De Palma M; Edwin L. Steele Laboratories, Department of Radiation Oncology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
Nat Cell Biol ; 21(2): 190-202, 2019 02.
Article en En | MEDLINE | ID: mdl-30598531

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Doxorrubicina / Paclitaxel / Vesículas Extracelulares / Neoplasias Pulmonares / Neoplasias Mamarias Experimentales Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Nat Cell Biol Año: 2019 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Doxorrubicina / Paclitaxel / Vesículas Extracelulares / Neoplasias Pulmonares / Neoplasias Mamarias Experimentales Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Nat Cell Biol Año: 2019 Tipo del documento: Article País de afiliación: Suiza